1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Ionis Acquires Akcea Therapeutics

M&A Deal Summary

Ionis Acquires Akcea Therapeutics

On August 31, 2020, Ionis acquired life science company Akcea Therapeutics

Acquisition Highlights
  • This is Ionis’ 3rd transaction in the Life Science sector.
  • This is Ionis’ 3rd transaction in the United States.
  • This is Ionis’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2020-08-31
Target Akcea Therapeutics
Sector Life Science
Buyer(s) Ionis
Deal Type Add-on Acquisition
Advisor(s) Cowen (Financial)
Ropes & Gray (Legal)

Target

Akcea Therapeutics

Boston, Massachusetts, United States
Akcea Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing medicines to treat patients with serious and rare diseases.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Ionis

Carlsbad, California, United States
Category Company
Founded 1989
Sector Life Science
Employees927
Revenue 705M USD (2024)
DESCRIPTION

Ionis is a drug development programs are focused on treating cardiovascular and metabolic diseases. Ionis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ionis was founded in 1989 and is based in Carlsbad, California.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Add-on Acquisition M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-06 Ibis Biosciences

Carlsbad, California, United States

Ibis Biosciences, Inc. is a molecular diagnostics business.

Sell $175M
Mergr

Solution for

Product

Company

Legal